| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
61,881 |
57,335 |
$28.53M |
| 0450 |
Emergency room services |
69,235 |
63,188 |
$20.06M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12,559 |
12,291 |
$9.31M |
| 99499 |
|
24,413 |
20,193 |
$7.21M |
| 80053 |
Comprehensive metabolic panel |
120,247 |
110,115 |
$4.88M |
| 0360 |
|
4,490 |
2,805 |
$4.76M |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,180 |
14,819 |
$4.00M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
61,044 |
54,498 |
$3.55M |
| 99199 |
Unlisted special service, procedure or report |
5,065 |
4,341 |
$3.46M |
| 0206 |
|
274 |
249 |
$3.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,997 |
9,212 |
$2.70M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,701 |
5,583 |
$2.49M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
123,169 |
111,544 |
$2.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,197 |
5,711 |
$2.24M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,469 |
25,361 |
$2.10M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,875 |
17,100 |
$2.01M |
| 59025 |
Fetal non-stress test |
11,669 |
3,227 |
$1.80M |
| 71045 |
Radiologic examination, chest; single view |
37,954 |
36,033 |
$1.74M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
14,278 |
5,399 |
$1.74M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,289 |
3,222 |
$1.66M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,651 |
3,587 |
$1.09M |
| 0762 |
|
2,678 |
1,316 |
$1.09M |
| 84484 |
|
35,027 |
31,914 |
$1.01M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,691 |
15,190 |
$891K |
| 81001 |
|
57,515 |
54,521 |
$840K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
21,241 |
20,822 |
$822K |
| 84702 |
|
27,752 |
25,752 |
$794K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,769 |
17,801 |
$732K |
| 0710 |
|
2,999 |
2,920 |
$731K |
| 71046 |
Radiologic examination, chest; 2 views |
11,575 |
11,096 |
$710K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,164 |
4,052 |
$706K |
| Z7502 |
|
19,006 |
18,864 |
$678K |
| 0300 |
|
380 |
343 |
$675K |
| 76801 |
|
3,941 |
3,405 |
$633K |
| 83690 |
|
28,525 |
27,104 |
$630K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,570 |
5,448 |
$613K |
| 0721 |
|
7,345 |
5,368 |
$546K |
| 93970 |
|
2,273 |
2,239 |
$540K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15,200 |
14,600 |
$498K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,607 |
3,937 |
$494K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,408 |
5,908 |
$490K |
| 0250 |
|
2,752 |
2,304 |
$472K |
| 82962 |
|
29,348 |
24,413 |
$470K |
| 87040 |
|
5,777 |
5,512 |
$463K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,480 |
4,307 |
$436K |
| 93971 |
|
1,997 |
1,937 |
$346K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,191 |
10,630 |
$338K |
| 76830 |
Ultrasound, transvaginal |
2,494 |
2,431 |
$333K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,168 |
1,118 |
$321K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,552 |
2,236 |
$312K |
| 97139 |
|
8,080 |
3,509 |
$282K |
| 70486 |
|
808 |
800 |
$279K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,227 |
4,042 |
$262K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,338 |
3,343 |
$248K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,535 |
4,139 |
$195K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
420 |
405 |
$175K |
| 73030 |
|
2,544 |
2,443 |
$175K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,186 |
3,118 |
$170K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,746 |
5,803 |
$169K |
| 70496 |
|
355 |
347 |
$165K |
| 97799 |
|
4,134 |
1,156 |
$162K |
| 70498 |
|
320 |
318 |
$159K |
| 72100 |
|
2,331 |
2,309 |
$155K |
| 73562 |
|
2,640 |
2,582 |
$147K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
342 |
337 |
$146K |
| 83880 |
|
6,134 |
5,859 |
$143K |
| J3490 |
Unclassified drugs |
2,329 |
1,634 |
$137K |
| Z9725 |
|
3,148 |
3,116 |
$135K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
857 |
785 |
$131K |
| 73630 |
|
2,157 |
2,115 |
$130K |
| 85379 |
|
4,762 |
4,650 |
$127K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,273 |
7,102 |
$121K |
| 73610 |
|
1,894 |
1,853 |
$120K |
| 86900 |
|
4,598 |
4,327 |
$110K |
| 87631 |
|
2,554 |
2,475 |
$104K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,238 |
3,168 |
$104K |
| 97161 |
|
2,037 |
1,951 |
$103K |
| 83735 |
|
6,460 |
5,961 |
$99K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
2,851 |
2,177 |
$99K |
| 85610 |
|
8,547 |
8,055 |
$98K |
| 93798 |
|
1,671 |
278 |
$94K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,500 |
3,441 |
$93K |
| 76770 |
|
860 |
834 |
$92K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,686 |
1,727 |
$92K |
| 82077 |
|
2,572 |
2,428 |
$92K |
| 0258 |
|
2,988 |
2,686 |
$91K |
| 71250 |
|
389 |
381 |
$88K |
| 72040 |
|
1,125 |
1,111 |
$88K |
| 70491 |
|
185 |
184 |
$87K |
| 86901 |
|
4,585 |
4,314 |
$87K |
| 83605 |
|
5,870 |
5,556 |
$87K |
| 73130 |
|
1,279 |
1,252 |
$75K |
| 87081 |
|
2,883 |
2,837 |
$74K |
| 87186 |
|
5,776 |
5,603 |
$72K |
| 84703 |
|
5,687 |
5,550 |
$70K |
| 85730 |
|
6,822 |
6,528 |
$64K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
235 |
223 |
$63K |
| 81003 |
|
7,421 |
7,177 |
$62K |
| 0270 |
|
375 |
349 |
$62K |
| 0730 |
|
339 |
307 |
$61K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,056 |
1,971 |
$61K |
| 93976 |
|
319 |
306 |
$57K |
| 80143 |
|
1,449 |
1,385 |
$55K |
| 94799 |
|
1,632 |
1,531 |
$55K |
| 93458 |
|
51 |
51 |
$54K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,502 |
1,465 |
$53K |
| 0160 |
|
52 |
25 |
$53K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
399 |
253 |
$53K |
| 87077 |
|
6,371 |
6,167 |
$52K |
| 80179 |
|
1,416 |
1,356 |
$52K |
| 77412 |
|
793 |
75 |
$51K |
| 76870 |
|
338 |
326 |
$51K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
800 |
729 |
$50K |
| 84145 |
|
2,486 |
2,408 |
$48K |
| 0324 |
|
311 |
284 |
$47K |
| 77336 |
|
754 |
312 |
$47K |
| 73502 |
|
1,102 |
1,084 |
$46K |
| 73110 |
|
847 |
817 |
$44K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,224 |
1,149 |
$43K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,235 |
1,185 |
$43K |
| 87510 |
|
2,590 |
2,547 |
$42K |
| 87480 |
|
2,595 |
2,551 |
$42K |
| 87660 |
|
2,598 |
2,554 |
$42K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19,115 |
18,184 |
$41K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,220 |
1,288 |
$41K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,699 |
9,724 |
$41K |
| 96376 |
|
1,252 |
1,169 |
$36K |
| 75574 |
|
86 |
86 |
$36K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,115 |
2,895 |
$36K |
| 71101 |
|
453 |
447 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
15,456 |
13,123 |
$35K |
| 97162 |
|
1,644 |
1,582 |
$34K |
| 74022 |
|
428 |
423 |
$32K |
| 94727 |
|
547 |
544 |
$32K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
220 |
208 |
$30K |
| 73080 |
|
502 |
486 |
$29K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
78 |
76 |
$29K |
| 90715 |
|
1,440 |
1,425 |
$29K |
| 82550 |
|
1,746 |
1,696 |
$28K |
| 86850 |
|
1,509 |
1,359 |
$28K |
| 74018 |
|
752 |
692 |
$28K |
| 0761 |
|
745 |
564 |
$28K |
| 0489 |
|
14 |
14 |
$28K |
| 73590 |
|
530 |
521 |
$26K |
| 94729 |
|
561 |
558 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
807 |
779 |
$24K |
| 80061 |
Lipid panel |
4,391 |
4,258 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,855 |
5,433 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,689 |
1,573 |
$21K |
| 86140 |
|
2,077 |
2,021 |
$21K |
| 93017 |
|
166 |
153 |
$21K |
| 0420 |
|
114 |
106 |
$21K |
| 29125 |
|
335 |
318 |
$20K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,705 |
15,281 |
$20K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,099 |
1,934 |
$20K |
| 72131 |
|
82 |
82 |
$20K |
| 84439 |
|
2,265 |
2,221 |
$19K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,573 |
3,407 |
$19K |
| 0760 |
|
380 |
297 |
$19K |
| 87070 |
|
1,163 |
1,141 |
$18K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,189 |
4,971 |
$18K |
| 85027 |
|
2,436 |
2,280 |
$18K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,440 |
1,392 |
$18K |
| 94060 |
|
164 |
163 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,717 |
4,557 |
$17K |
| 88304 |
|
718 |
709 |
$16K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,346 |
3,939 |
$16K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
380 |
193 |
$16K |
| 95816 |
|
173 |
172 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
588 |
569 |
$15K |
| 86308 |
|
666 |
661 |
$15K |
| J2704 |
Injection, propofol, 10 mg |
4,114 |
3,989 |
$15K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
58 |
58 |
$14K |
| 97803 |
|
352 |
335 |
$13K |
| 84550 |
|
2,018 |
1,881 |
$13K |
| J1756 |
Injection, iron sucrose, 1 mg |
124 |
60 |
$13K |
| 85652 |
|
1,860 |
1,816 |
$12K |
| 83615 |
|
1,171 |
1,063 |
$11K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,455 |
5,231 |
$11K |
| 0352 |
|
12 |
12 |
$11K |
| 72072 |
|
121 |
120 |
$11K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,818 |
4,569 |
$10K |
| 94010 |
|
145 |
144 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,818 |
1,787 |
$10K |
| 88307 |
|
132 |
122 |
$10K |
| 87427 |
|
295 |
288 |
$9K |
| 74174 |
|
13 |
13 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
375 |
322 |
$9K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
595 |
425 |
$9K |
| 0272 |
|
143 |
136 |
$9K |
| 73140 |
|
183 |
173 |
$9K |
| 73090 |
|
174 |
168 |
$8K |
| G0378 |
Hospital observation service, per hour |
117 |
112 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,857 |
2,637 |
$8K |
| 82728 |
|
2,864 |
2,729 |
$8K |
| 82570 |
|
2,769 |
2,666 |
$8K |
| 93975 |
|
37 |
36 |
$7K |
| V2632 |
Posterior chamber intraocular lens |
336 |
324 |
$7K |
| 82009 |
|
902 |
863 |
$7K |
| 87045 |
|
309 |
302 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,613 |
4,224 |
$6K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
83 |
76 |
$6K |
| 0370 |
|
288 |
271 |
$6K |
| 96367 |
|
129 |
82 |
$6K |
| 0402 |
|
13 |
12 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,004 |
4,813 |
$6K |
| 97163 |
|
87 |
86 |
$5K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
813 |
748 |
$5K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,519 |
1,416 |
$5K |
| 86141 |
|
302 |
300 |
$5K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
462 |
452 |
$5K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
32 |
32 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
3,011 |
2,754 |
$4K |
| 87205 |
|
822 |
796 |
$4K |
| 97166 |
|
155 |
151 |
$4K |
| 87046 |
|
309 |
302 |
$4K |
| 97802 |
|
53 |
53 |
$4K |
| 83540 |
|
2,500 |
2,378 |
$4K |
| 73564 |
|
53 |
49 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,324 |
2,143 |
$4K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
19 |
19 |
$4K |
| 83970 |
|
652 |
644 |
$4K |
| 95819 |
|
25 |
25 |
$4K |
| 0320 |
|
13 |
13 |
$4K |
| 83550 |
|
2,389 |
2,306 |
$3K |
| 85670 |
|
124 |
122 |
$3K |
| 85347 |
|
164 |
145 |
$3K |
| 82607 |
|
1,703 |
1,658 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
748 |
597 |
$3K |
| 85384 |
|
93 |
92 |
$3K |
| 74230 |
|
31 |
31 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
39 |
37 |
$3K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
271 |
261 |
$3K |
| 77334 |
|
16 |
13 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
181 |
172 |
$2K |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
43 |
41 |
$2K |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
17 |
12 |
$2K |
| Z7500 |
|
65 |
52 |
$2K |
| 71020 |
|
63 |
32 |
$2K |
| 84100 |
|
651 |
587 |
$2K |
| 92611 |
|
31 |
31 |
$2K |
| 87807 |
|
59 |
53 |
$2K |
| 73060 |
|
37 |
37 |
$2K |
| 73552 |
|
53 |
52 |
$2K |
| 29515 |
|
14 |
13 |
$2K |
| 12001 |
|
25 |
24 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
78 |
74 |
$1K |
| 72110 |
|
13 |
13 |
$1K |
| 82043 |
|
1,598 |
1,568 |
$1K |
| 73660 |
|
26 |
26 |
$1K |
| 96415 |
|
22 |
14 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
72 |
71 |
$1K |
| 80069 |
|
889 |
868 |
$1K |
| 82805 |
|
27 |
26 |
$1K |
| 87641 |
|
99 |
92 |
$1K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
151 |
130 |
$1K |
| 87634 |
|
28 |
27 |
$1K |
| 72070 |
|
12 |
12 |
$1K |
| 82746 |
|
491 |
479 |
$998.70 |
| 87147 |
|
124 |
122 |
$940.15 |
| 97116 |
|
102 |
79 |
$922.44 |
| 70360 |
|
16 |
16 |
$878.26 |
| V2630 |
Anterior chamber intraocular lens |
40 |
40 |
$846.21 |
| 87449 |
|
98 |
96 |
$816.58 |
| 71010 |
|
34 |
15 |
$792.00 |
| 82803 |
|
27 |
24 |
$659.36 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14 |
14 |
$625.11 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
93 |
91 |
$523.43 |
| 73620 |
|
12 |
12 |
$510.55 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
51 |
50 |
$497.72 |
| 82140 |
|
31 |
30 |
$460.09 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
62 |
45 |
$459.12 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
40 |
39 |
$449.69 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
75 |
68 |
$401.16 |
| 10060 |
|
13 |
13 |
$386.04 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
15 |
12 |
$356.07 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
78 |
71 |
$293.62 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
115 |
110 |
$280.46 |
| 87324 |
|
32 |
31 |
$260.32 |
| 82784 |
|
105 |
101 |
$247.09 |
| 80074 |
|
13 |
13 |
$194.40 |
| J1953 |
Injection, levetiracetam, 10 mg |
13 |
13 |
$172.91 |
| 84153 |
|
40 |
39 |
$142.62 |
| 88300 |
|
15 |
15 |
$138.04 |
| J1815 |
Injection, insulin, per 5 units |
35 |
12 |
$129.33 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
27 |
24 |
$117.39 |
| 87340 |
|
40 |
37 |
$112.04 |
| J1940 |
Injection, furosemide, up to 20 mg |
31 |
27 |
$106.02 |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
14 |
12 |
$96.11 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
38 |
38 |
$95.62 |
| J1630 |
Injection, haloperidol, up to 5 mg |
40 |
37 |
$92.80 |
| 85007 |
|
12 |
12 |
$85.62 |
| Z7610 |
|
20 |
13 |
$75.47 |
| 87075 |
|
13 |
13 |
$73.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
40 |
40 |
$71.13 |
| 85045 |
|
26 |
24 |
$69.96 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
13 |
$32.90 |
| 82565 |
|
24 |
24 |
$24.79 |
| 84132 |
|
13 |
12 |
$21.83 |
| C1769 |
Guide wire |
13 |
13 |
$13.78 |
| 82378 |
|
24 |
24 |
$11.82 |
| 84165 |
|
13 |
13 |
$5.55 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
13 |
$4.37 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
15 |
15 |
$0.01 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
14 |
14 |
$0.00 |